Sep 2026· Frontiers in Bioscience· Vol 31 9, pp.
55463
· 0 citations· 37 references
Medicine
TL;DR
The observed proteomic changes may reflect early adaptive and compensatory mechanisms supporting mitochondrial function under increased energetic and oxidative load and highlight pathways that may represent promising candidates for targeted therapeutic modulation in diabetic cardiac dysfunction.
Abstract
Background
Mitochondria play a central role in cardiac energy metabolism and dynamically adapt to changes in metabolic demand. However, the early mitochondrial adaptations accompanying the acute phase of diabetes mellitus remain insufficiently understood. This study aimed to characterise diabetes-induced mitochondrial remodelling in the rat heart.
Methods
Diabetes was induced using an established streptozotocin-induced rat model. Cardiac mitochondrial proteomes were analyzed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in control and diabetic animals. Differential protein abundance was assessed by statistical comparison between groups using the limma package in R, and machine learning classification was used to identify proteins with the strongest discriminatory power between control and diabetic states.
Results
Diabetes was associated with distinct mitochondrial proteomic remodelling. In the diabetic group, monoamine oxidase A (AOFA, padjust = 0.003) was markedly upregulated, fatty acid β-oxidation-related enzymes including dienoyl-CoA isomerase (ECH1, padjust < 0.001) and dienoyl-CoA reductase (DECR, padjust = 0.003) showed increased abundance, and respiratory chain complex I components, particularly NADH-ubiquinone oxidoreductase 75 kDa subunit (NDUS1, padjust = 0.016) and NADH dehydrogenase [ubiquinone] iron-sulfur protein 2 (NDUS2, padjust = 0.016), were elevated. Machine learning analysis consistently identified AOFA and key metabolic proteins as the strongest discriminators between diabetic and control animals (n = 6 per group). These changes indicate a coordinated shift towards enhanced lipid utilisation, altered mitochondrial respiratory function, and involvement of redox-associated processes.
Conclusions
The observed proteomic changes may reflect early adaptive and compensatory mechanisms supporting mitochondrial function under increased energetic and oxidative load and highlight pathways that may represent promising candidates for targeted therapeutic modulation in diabetic cardiac dysfunction.
Diabetic cardiomyopathy (DCM) is a major myocardial complication of type 2 diabetes and a contributor to heart failure. However, coordinated remodeling across the cardiac transcriptome, proteome and metabolome in DCM remains incompletely defined. Type 2 diabetes was induced in mice by a high-fat diet combined with sing...
Diabetes mellitus increases the risk of heart failure by inducing progressive myocardial structural and functional changes (diabetic cardiomyopathy, DCM). Emerging evidence implicates the gut microbiome and microbiome-derived metabolites in cardiometabolic disease, but the integrated relationships among gut commu...
Jin-Xin Wang, Zi-Fan Zhu, Kun Wang et al.· BMC Microbiology· 0 citations
Diabetes mellitus (DM) is a progressive metabolic disorder in which mitochondrial dysfunction is increasingly recognized as a central contributor to metabolic deterioration and diabetic complications. However, whether dysregulated mitochondrial dynamics represents a primary pathogenic driver, an adaptive response, or a...
Guo-Hua Wang, Yi-Ge Zhao, Gai-Ting Liu et al.· International Journal of Mol...· 0 citations
This Review positions mito-ER-LD contact sites not simply as structural interfaces, but as core nodes that regulate lipid metabolic reprogramming in T2DM, thereby providing a mechanistic framework for targeting organelle crosstalk in metabolic disease.
Xin-Yi Fang, Jia-Qi Gao, Yan Wang et al.· Journal of Lipid Research· 0 citations
Cardiovascular diseases (CVDs) are a leading global cause of mortality and disease burden, closely associated with the remodeling of myocardial energy metabolism. Acylcarnitines (Acs) are key intermediates in the carnitine shuttle and fatty acid β-oxidation (FAO) processes. They play a critical role in transporting lon...
Jia-Zhen Wu, Yi Zhang, Jia-Wei Liu et al.· International Journal of Car...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.